In a recent court filing, patent holding company VirnetX has asked the judge presiding over its patent-infringement lawsuit against tech giant Apple to increase the damages in the case by a minimum of $190 million.
VirnetX’s recent request to the court to bump up the damages in its patent-infringement lawsuit against Apple comes a few months after the company won a $625 million ruling, from an East Texas jury, in the case in February this year.
Along with seeking an increase in damages from Apple in the patent-infringement case, VirnetX has also urged the judge to issue a permanent injunction which will force Apple to eliminate a few key features -- including Facetime, iMessage, and always-mode VPN On Demand -- from its devices in the future.
VirnetX’s patent-infringement lawsuit against Apple chiefly pivots around four patents owned by the company, and allegedly violated by Apple. The lawsuit was filed by VirnetX in 2012, in the U.S. District Court in Eastern Texas.
While VirnetX wants the court to increase the $625 milllion award in the patent-infringement case by another $190 million, Apple is already appealing the February ruling. Moreover, Apple has also filed for a mistrial, by claiming that the closing arguments made by VirnetX attorneys were "outside the evidence and blatantly misrepresented the testimony of Apple's witnesses."
In an apparent attempt to enhance the visual experience for Google search users carrying out searches on their mobile devices, Google has introduced a new 'Rich Cards' search format.
The Rich Cards search format was debuted by Google on...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
During the course of Thursday proceedings in the ongoing legal scuffle between Google and Oracle...
China's Dakang Australia has been looking forward to sign a deal to buy Kidman, one of the Australia's biggest beef producers and owner of farm assets. However, the deal could be cancelled as the Australian government said it found that selling...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
In a Thursday post on the company blog, Alphabet Inc. subsidiary Google announced the launch of...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
In a Friday announcement, Microsoft-owned game developer...
In a statement released on Wednesday, popular...
During the course of Thursday proceedings in the ongoing...
In an announcement made at the I/O developer conference...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).